Supplementary Table S1 from Estrogen Therapy Induces Receptor-Dependent DNA Damage Enhanced by PARP Inhibition in ER+ Breast Cancer

<p>Table S1. Results of genome-wide CRISPR/Cas9 screening of HCC-1428/LTED cells.</p>

Պահպանված է:
Մատենագիտական մանրամասներ
Հիմնական հեղինակ: Nicole A. Traphagen (16677391) (author)
Այլ հեղինակներ: Gary N. Schwartz (16005870) (author), Steven Tau (16677394) (author), Alyssa M. Roberts (16677397) (author), Amanda Jiang (15117790) (author), Sarah R. Hosford (16677400) (author), Jonathan D. Marotti (16005879) (author), Abigail E. Goen (16677403) (author), Bianca A. Romo (16677406) (author), Anneka L. Johnson (16677409) (author), Emily-Claire K. Duffy (16677412) (author), Eugene Demidenko (16005894) (author), Paul Heverly (16677415) (author), Yaron Mosesson (16677418) (author), Shannon M. Soucy (16005888) (author), Fred Kolling (16005891) (author), Todd W. Miller (16005897) (author)
Հրապարակվել է: 2025
Խորագրեր:
Ցուցիչներ: Ավելացրեք ցուցիչ
Չկան պիտակներ, Եղեք առաջինը, ով նշում է այս գրառումը!
_version_ 1849927632821420032
author Nicole A. Traphagen (16677391)
author2 Gary N. Schwartz (16005870)
Steven Tau (16677394)
Alyssa M. Roberts (16677397)
Amanda Jiang (15117790)
Sarah R. Hosford (16677400)
Jonathan D. Marotti (16005879)
Abigail E. Goen (16677403)
Bianca A. Romo (16677406)
Anneka L. Johnson (16677409)
Emily-Claire K. Duffy (16677412)
Eugene Demidenko (16005894)
Paul Heverly (16677415)
Yaron Mosesson (16677418)
Shannon M. Soucy (16005888)
Fred Kolling (16005891)
Todd W. Miller (16005897)
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author_facet Nicole A. Traphagen (16677391)
Gary N. Schwartz (16005870)
Steven Tau (16677394)
Alyssa M. Roberts (16677397)
Amanda Jiang (15117790)
Sarah R. Hosford (16677400)
Jonathan D. Marotti (16005879)
Abigail E. Goen (16677403)
Bianca A. Romo (16677406)
Anneka L. Johnson (16677409)
Emily-Claire K. Duffy (16677412)
Eugene Demidenko (16005894)
Paul Heverly (16677415)
Yaron Mosesson (16677418)
Shannon M. Soucy (16005888)
Fred Kolling (16005891)
Todd W. Miller (16005897)
author_role author
dc.creator.none.fl_str_mv Nicole A. Traphagen (16677391)
Gary N. Schwartz (16005870)
Steven Tau (16677394)
Alyssa M. Roberts (16677397)
Amanda Jiang (15117790)
Sarah R. Hosford (16677400)
Jonathan D. Marotti (16005879)
Abigail E. Goen (16677403)
Bianca A. Romo (16677406)
Anneka L. Johnson (16677409)
Emily-Claire K. Duffy (16677412)
Eugene Demidenko (16005894)
Paul Heverly (16677415)
Yaron Mosesson (16677418)
Shannon M. Soucy (16005888)
Fred Kolling (16005891)
Todd W. Miller (16005897)
dc.date.none.fl_str_mv 2025-11-25T13:21:08Z
dc.identifier.none.fl_str_mv 10.1158/1078-0432.30708354
dc.relation.none.fl_str_mv https://figshare.com/articles/dataset/Supplementary_Table_S1_from_Estrogen_Therapy_Induces_Receptor-Dependent_DNA_Damage_Enhanced_by_PARP_Inhibition_in_ER_Breast_Cancer/30708354
dc.rights.none.fl_str_mv CC BY
info:eu-repo/semantics/openAccess
dc.subject.none.fl_str_mv Cancer
Therapeutic Research and Development
Breast Cancer
Drug Mechanisms
Cellular responses to anticancer drugs
Drug Resistance
Reversal of drug resistance
dc.title.none.fl_str_mv Supplementary Table S1 from Estrogen Therapy Induces Receptor-Dependent DNA Damage Enhanced by PARP Inhibition in ER+ Breast Cancer
dc.type.none.fl_str_mv Dataset
info:eu-repo/semantics/publishedVersion
dataset
description <p>Table S1. Results of genome-wide CRISPR/Cas9 screening of HCC-1428/LTED cells.</p>
eu_rights_str_mv openAccess
id Manara_8c1f656d28b21fba8da99f0e798e33df
identifier_str_mv 10.1158/1078-0432.30708354
network_acronym_str Manara
network_name_str ManaraRepo
oai_identifier_str oai:figshare.com:article/30708354
publishDate 2025
repository.mail.fl_str_mv
repository.name.fl_str_mv
repository_id_str
rights_invalid_str_mv CC BY
spelling Supplementary Table S1 from Estrogen Therapy Induces Receptor-Dependent DNA Damage Enhanced by PARP Inhibition in ER+ Breast CancerNicole A. Traphagen (16677391)Gary N. Schwartz (16005870)Steven Tau (16677394)Alyssa M. Roberts (16677397)Amanda Jiang (15117790)Sarah R. Hosford (16677400)Jonathan D. Marotti (16005879)Abigail E. Goen (16677403)Bianca A. Romo (16677406)Anneka L. Johnson (16677409)Emily-Claire K. Duffy (16677412)Eugene Demidenko (16005894)Paul Heverly (16677415)Yaron Mosesson (16677418)Shannon M. Soucy (16005888)Fred Kolling (16005891)Todd W. Miller (16005897)CancerTherapeutic Research and DevelopmentBreast CancerDrug MechanismsCellular responses to anticancer drugsDrug ResistanceReversal of drug resistance<p>Table S1. Results of genome-wide CRISPR/Cas9 screening of HCC-1428/LTED cells.</p>2025-11-25T13:21:08ZDatasetinfo:eu-repo/semantics/publishedVersiondataset10.1158/1078-0432.30708354https://figshare.com/articles/dataset/Supplementary_Table_S1_from_Estrogen_Therapy_Induces_Receptor-Dependent_DNA_Damage_Enhanced_by_PARP_Inhibition_in_ER_Breast_Cancer/30708354CC BYinfo:eu-repo/semantics/openAccessoai:figshare.com:article/307083542025-11-25T13:21:08Z
spellingShingle Supplementary Table S1 from Estrogen Therapy Induces Receptor-Dependent DNA Damage Enhanced by PARP Inhibition in ER+ Breast Cancer
Nicole A. Traphagen (16677391)
Cancer
Therapeutic Research and Development
Breast Cancer
Drug Mechanisms
Cellular responses to anticancer drugs
Drug Resistance
Reversal of drug resistance
status_str publishedVersion
title Supplementary Table S1 from Estrogen Therapy Induces Receptor-Dependent DNA Damage Enhanced by PARP Inhibition in ER+ Breast Cancer
title_full Supplementary Table S1 from Estrogen Therapy Induces Receptor-Dependent DNA Damage Enhanced by PARP Inhibition in ER+ Breast Cancer
title_fullStr Supplementary Table S1 from Estrogen Therapy Induces Receptor-Dependent DNA Damage Enhanced by PARP Inhibition in ER+ Breast Cancer
title_full_unstemmed Supplementary Table S1 from Estrogen Therapy Induces Receptor-Dependent DNA Damage Enhanced by PARP Inhibition in ER+ Breast Cancer
title_short Supplementary Table S1 from Estrogen Therapy Induces Receptor-Dependent DNA Damage Enhanced by PARP Inhibition in ER+ Breast Cancer
title_sort Supplementary Table S1 from Estrogen Therapy Induces Receptor-Dependent DNA Damage Enhanced by PARP Inhibition in ER+ Breast Cancer
topic Cancer
Therapeutic Research and Development
Breast Cancer
Drug Mechanisms
Cellular responses to anticancer drugs
Drug Resistance
Reversal of drug resistance